Advertisement

Authors’ Reply to “Diffuse Involvement of Pancreas Should Raise Suspicion of Mahvash Disease, an Autosomal Recessive Pancreatic Neuroendocrine Tumor Syndrome”

Published:September 28, 2022DOI:https://doi.org/10.1016/j.acra.2022.08.004
      We appreciate the letter from Dr Yu regarding our paper on diffuse pancreatic involvement (
      • He M
      • Wang X
      • Xu J
      • et al.
      Diffuse involvement of pancreas is not always autoimmune pancreatitis.
      ) and his comments on Mahvash disease (
      • Yu R.
      Mahvash disease: 10 years after discovery.
      ), an autosomal recessive pancreatic neuroendocrine tumor syndrome, which also exhibits diffuse involvement of pancreas on imaging, which we had ignored.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • He M
        • Wang X
        • Xu J
        • et al.
        Diffuse involvement of pancreas is not always autoimmune pancreatitis.
        Acad Radiol. 2022; 29(10):1523-31;
        • Yu R.
        Mahvash disease: 10 years after discovery.
        Pancreas. 2018; 47: 511-515
        • Gild ML
        • Tsang V
        • Samra J
        • et al.
        Hypercalcemia in glucagon cell hyperplasia and neoplasia (mahvash syndrome): a new association.
        The J clin endocrinol metab. 2018; 103: 3119-3123